Source:http://linkedlifedata.com/resource/pubmed/id/20932570
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-11-24
|
pubmed:abstractText |
Injectable scaffolds made of biodegradable biomaterials can stabilize a myocardial infarct and promote cardiac repair. Here, we describe the synthesis of a new, temperature-sensitive, aliphatic polyester hydrogel (HG) conjugated with vascular endothelial growth factor (VEGF) and evaluate its effects on cardiac recovery after a myocardial infarction (MI). Seven days after coronary ligation in rats, PBS, HG, or HG mixed or conjugated with VEGF (HG + VEGF or HG-VEGF, respectively) was injected around the infarct (n = 8-11/group). Function was evaluated by echocardiography at multiple time points. Pressure-volume measurements were taken and infarct morphometry and blood vessel density were assessed at 35 days after injection. HG-VEGF provided localized, sustained VEGF function. Compared with outcomes in the PBS group, fractional shortening, ventricular volumes, preload recruitable stroke work, and end-systolic elastance were all preserved (p < 0.05) in the HG and HG + VEGF groups, and further preserved in the HG-VEGF group. Conjugated VEGF also produced the highest blood vessel density (p < 0.05). The infarct thinned and dilated after PBS injection, but was smaller and thicker in hearts treated with HG (p < 0.05). Our temperature-sensitive HG attenuated adverse cardiac remodeling and improved ventricular function when injected after an MI. VEGF delivery enhanced these effects when the VEGF was conjugated to the HG.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1878-5905
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
579-86
|
pubmed:meshHeading |
pubmed-meshheading:20932570-Animals,
pubmed-meshheading:20932570-Hydrogel,
pubmed-meshheading:20932570-Injections,
pubmed-meshheading:20932570-Myocardial Infarction,
pubmed-meshheading:20932570-Neovascularization, Physiologic,
pubmed-meshheading:20932570-Rats,
pubmed-meshheading:20932570-Rats, Sprague-Dawley,
pubmed-meshheading:20932570-Tissue Engineering,
pubmed-meshheading:20932570-Tissue Scaffolds,
pubmed-meshheading:20932570-Vascular Endothelial Growth Factor A
|
pubmed:year |
2011
|
pubmed:articleTitle |
Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel.
|
pubmed:affiliation |
Division of Cardiovascular Surgery, University Health Network and Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|